Amway, direct selling FMCG firm, is planning to make an investment of Rs 170 crore in the next two to three years in the country to boost research and development (R&D), manufacturing automation and innovation.
The company also plans to strengthen its nutrition portfolio, which accounts for over 60 percent of its revenue, by exploring adjacent and expanded spaces around the nutrition segment.
The amount will be used to boost research and development (R&D), manufacturing automation, innovation and science, and home delivery as well as to strengthen its digital capabilities to ensure efficient functioning.
Moving forward in 2021, the company’s growth will be fuelled by key levers that include increasing awareness around nutrition and immunity, accelerated digital adoption and a robust supply chain with seamless last-mile delivery.
The company will further strengthen the segment with a huge focus on herbal category, while also developing affordable herbal nutrition supplementation.
The company is also exploring adjacent and expanded spaces around the nutrition segment.